- KR₩123bn
- KR₩79bn
- KR₩16bn
- 66
- 27
- 72
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.03 | ||
| PEG Ratio (f) | 0.82 | ||
| EPS Growth (f) | 30.04% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.95 | ||
| Price to Tang. Book | 1.96 | ||
| Price to Free Cashflow | 26.01 | ||
| Price to Sales | 7.68 | ||
| EV to EBITDA | 12.99 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.66% | ||
| Return on Equity | 7.39% | ||
| Operating Margin | 30.2% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | n/a | 15,855.32 | 15,592.09 | 16,066.43 | 19,700 | 22,800 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +33 | -19.4 | +31.88 | +27.3 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bio-FD&C Co Ltd is a Korea-based company mainly engaged in the and research, development and manufacture of plant cell derived active substances and plant cell derived pharmacological substances. The Company is mainly engaged in the manufacture and sale of soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, acanthopanax koreanum adventitious root culture extract. The Company's products are mainly used as materials for cosmeceuticals, health functional foods and pharmaceuticals.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 11th, 2005
- Public Since
- February 21st, 2022
- No. of Shareholders
- 4,610
- No. of Employees
- 76
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 8,528,949
- Address
- Incheon, INCHEON, 21990
- Web
- https://www.biofdnc.com/
- Phone
- +82 328112027
- Auditors
- Dongseong Accounting Corporation
Upcoming Events for 251120
Similar to 251120
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:36 UTC, shares in Bio-FD&C Co are trading at KR₩14,460. This share price information is delayed by 15 minutes.
Shares in Bio-FD&C Co last closed at KR₩14,460 and the price had moved by +1.4% over the past 365 days. In terms of relative price strength the Bio-FD&C Co share price has outperformed the FTSE Developed Asia Pacific Index by +1.74% over the past year.
The overall consensus recommendation for Bio-FD&C Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreBio-FD&C Co does not currently pay a dividend.
Bio-FD&C Co does not currently pay a dividend.
Bio-FD&C Co does not currently pay a dividend.
To buy shares in Bio-FD&C Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩14,460, shares in Bio-FD&C Co had a market capitalisation of KR₩123bn.
Here are the trading details for Bio-FD&C Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 251120
Based on an overall assessment of its quality, value and momentum Bio-FD&C Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Bio-FD&C Co is KR₩20,000. That is 38.31% above the last closing price of KR₩14,460.
Analysts covering Bio-FD&C Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩696 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bio-FD&C Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -3.31%.
As of the last closing price of KR₩14,460, shares in Bio-FD&C Co were trading -0.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bio-FD&C Co PE ratio based on its reported earnings over the past 12 months is 19.03. The shares last closed at KR₩14,460.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bio-FD&C Co's directors